U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C27H25F2NO4
Molecular Weight 465.4885
Optical Activity ( + / - )
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OMILOXETINE

SMILES

FC1=CC=C(C=C1)[C@H]2CCN(CC(=O)C3=CC=C(F)C=C3)C[C@@H]2COC4=CC=C5OCOC5=C4

InChI

InChIKey=FAHGZANUNVVDFL-HYBUGGRVSA-N
InChI=1S/C27H25F2NO4/c28-21-5-1-18(2-6-21)24-11-12-30(15-25(31)19-3-7-22(29)8-4-19)14-20(24)16-32-23-9-10-26-27(13-23)34-17-33-26/h1-10,13,20,24H,11-12,14-17H2/t20-,24-/m1/s1

HIDE SMILES / InChI

Molecular Formula C27H25F2NO4
Molecular Weight 465.4885
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Omiloxetine, a serotonin uptake inhibitor was developed in Spain for the treatment of depression. However, in 2005, it was abandoned.

Originator

Approval Year

Substance Class Chemical
Record UNII
H8YI0SSF7B
Record Status Validated (UNII)
Record Version